Viking Therapeutics Inc [VKTX] stock prices are up 3.98% to $33.98 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VKTX shares have gain 2.35% over the last week, with a monthly amount glided 20.54%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Viking Therapeutics Inc [NASDAQ: VKTX] stock has seen the most recent analyst activity on April 29, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $104. Previously, Goldman started tracking the stock with Neutral rating on April 08, 2025, and set its price target to $30. On February 13, 2025, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $102 on the stock. Citigroup started tracking the stock assigning a Neutral rating and suggested a price target of $38 on February 07, 2025. Piper Sandler initiated its recommendation with a Overweight. B. Riley Securities started tracking with a Buy rating for this stock on November 22, 2024, and assigned it a price target of $109. In a note dated November 04, 2024, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $90 to $102.
The stock price of Viking Therapeutics Inc [VKTX] has been fluctuating between $18.92 and $81.73 over the past year. Currently, Wall Street analysts expect the stock to reach $75 within the next 12 months. Viking Therapeutics Inc [NASDAQ: VKTX] shares were valued at $33.98 at the most recent close of the market. An investor can expect a potential return of 120.72% based on the average VKTX price forecast.
Analyzing the VKTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.2 and Total Capital is -0.27. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Viking Therapeutics Inc [NASDAQ:VKTX]’s Current Ratio is 25.86. In addition, the Quick Ratio stands at 25.86 and the Cash Ratio stands at 1.06.
Transactions by insiders
Recent insider trading involved Lian Brian, President & CEO, that happened on Jul 03 ’25 when 26889.0 shares were sold. Chief Financial Officer, ZANTE GREG completed a deal on Jul 03 ’25 to sell 4266.0 shares. Meanwhile, Chief Operating Officer Mancini Marianna sold 4266.0 shares on Jul 03 ’25.
